H. Faber

881 total citations
11 papers, 644 citations indexed

About

H. Faber is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, H. Faber has authored 11 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Orthopedics and Sports Medicine, 8 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in H. Faber's work include Bone health and osteoporosis research (9 papers), Bone health and treatments (8 papers) and Bone and Joint Diseases (7 papers). H. Faber is often cited by papers focused on Bone health and osteoporosis research (9 papers), Bone health and treatments (8 papers) and Bone and Joint Diseases (7 papers). H. Faber collaborates with scholars based in Germany, Switzerland and Italy. H. Faber's co-authors include J. D. Ringe, A. Dorst, P. Farahmand, E. Schacht, Volker W. Rahlfs, Oliver Bock, H Minne, S. Schwalen, Dieter Felsenberg and Michael Pfeifer and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Osteoporosis International and Journal of Bone and Mineral Metabolism.

In The Last Decade

H. Faber

11 papers receiving 603 citations

Peers

H. Faber

OSM

ONCOL

MB

SURGE

PFM

A. Dorst Germany

John Graham Australia

J. A. Clowes United Kingdom

Elizabeth Shane United States

Simona De Geronimo Italy

Dennis M. Black United States

Jessica Fleischer United States

Mariela Varsavsky Spain

Märit Wallander Sweden

Anna Kepley United States

A. Dorst Germany

H. Faber

588 ×1.1

OSM

420 ×1.1

ONCOL

185 ×1.1

MB

145 ×1.0

SURGE

102 ×1.0

PFM

Citations per year, relative to H. Faber H. Faber (= 1×) peers A. Dorst

Countries citing papers authored by H. Faber

Since Specialization

Citations

This map shows the geographic impact of H. Faber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Faber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Faber more than expected).

Fields of papers citing papers by H. Faber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Faber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Faber. The network helps show where H. Faber may publish in the future.

Co-authorship network of co-authors of H. Faber

This figure shows the co-authorship network connecting the top 25 collaborators of H. Faber. A scholar is included among the top collaborators of H. Faber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Faber. H. Faber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Ringe, J. D., P. Farahmand, H. Faber, & A. Dorst. (2008). Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Rheumatology International. 29(3). 311–315. 67 indexed citations

2.

Ringe, J. D., H. Faber, & P. Farahmand. (2005). Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy. Journal of Bone and Mineral Metabolism. 24(1). 87–93. 7 indexed citations

3.

Ringe, J. D., et al.. (2005). Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study. Rheumatology International. 25(4). 296–300. 6 indexed citations

4.

Ringe, J. D., H. Faber, P. Farahmand, & A. Dorst. (2005). Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatology International. 26(5). 427–431. 120 indexed citations

5.

Ringe, J. D., A. Dorst, & H. Faber. (2005). Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate. Osteoporosis International. 16(12). 2063–2068. 68 indexed citations

6.

Ringe, J. D., et al.. (2005). Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.. PubMed. 76. 33–40. 14 indexed citations

7.

Schacht, E., J. D. Ringe, A. Dorst, Volker W. Rahlfs, & H. Faber. (2004). Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatology International. 24(2). 63–70. 35 indexed citations

8.

Ringe, J. D., et al.. (2004). Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study. Rheumatology International. 24(2). 110–113. 76 indexed citations

9.

Ringe, J. D., et al.. (2003). Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study. Osteoporosis International. 14(10). 801–807. 131 indexed citations

10.

Ringe, J. D., H. Faber, Oliver Bock, et al.. (2002). Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatology International. 22(5). 199–203. 26 indexed citations

11.

Ringe, J. D., H. Faber, & A. Dorst. (2001). Alendronate Treatment of Established Primary Osteoporosis in Men: Results of a 2-Year Prospective Study. The Journal of Clinical Endocrinology & Metabolism. 86(11). 5252–5255. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact